Elevated serum FGF21 was found in patients with higher Body Mass Index (BMI) values, type 2 diabetes mellitus, metabolic syndrome, coronary heart disease, chronic and acute renal dysfunction, hepatitis, liver fatty degeneration and cirrhosis [12,19,20]. This evidence concerns the gene FGF21 and coronary artery disorder.